Reply: To PMID 23907995

Affiliations

Comment

Jerry R Mendell et al. Ann Neurol. 2014 Feb.

. 2014 Feb;75(2):329.

doi: 10.1002/ana.24084. Epub 2014 Feb 24.

No abstract available

Comment on

Eteplirsen for the treatment of Duchenne muscular dystrophy.
Mendell JR, Rodino-Klapac LR, Sahenk Z, Roush K, Bird L, Lowes LP, Alfano L, Gomez AM, Lewis S, Kota J, Malik V, Shontz K, Walker CM, Flanigan KM, Corridore M, Kean JR, Allen HD, Shilling C, Melia KR, Sazani P, Saoud JB, Kaye EM; Eteplirsen Study Group. Mendell JR, et al. Ann Neurol. 2013 Nov;74(5):637-47. doi: 10.1002/ana.23982. Epub 2013 Sep 10. Ann Neurol. 2013. PMID: 23907995 Clinical Trial.
Questions about efficacy of exon-skipping therapy for duchenne muscular dystrophy.
Bhagavati S. Bhagavati S. Ann Neurol. 2014 Feb;75(2):326-9. doi: 10.1002/ana.24085. Epub 2014 Feb 3. Ann Neurol. 2014. PMID: 24327535 No abstract available.